Neurology is one of the most impressive branch of medicine. The nervous system comprises of the brain the spinal cord, the nerves emanating from them and their innervations of muscle fibres...more

Science & Spirituality

Actually, science is merely one part of Jain religion. If we take science, then right from atomic science to biological sciences, from mathematics to astronomy...more


This presentation is meant to imply that real spiritual experiences are not hallucinations, but they are neurological and physiological events...more


The research I do is on very fascinating subjects - bridging science & spirituality. one of the areas, that I have worked extensively is prolonged fasting & I have created a working hypothesis...more

Papers, Publications & Research Work

  1. EEG in Epilepsy :
    Dissertation submitted to Gujarat University for M.D., Degree.
  2. Clinical, EEG, CT, MRI correlation in partial seizures :
    Dissertation submitted to Bombay University for D.M. (Neurology) degree.
  3. Subacute sclerosing panencephalitis' :
    A study of 12 cases. Paper presented at 7th annual conference of Association of Physicians of Gujarat 1986. FIRST PRIZE WAS AWARDED to this paper.
  4. Paraplegia :
    Article published in JAPI : June 1984. Postgraduate clinic.
  5. Strokes in young in west central India' :
    Some observations on changing trends in morbidity and mortality : JAPI : June 1988.
  6. The efficacy of MRI V/S CT Scan in partial seizure :
    18th international epilepsy congress, New Delhi 1989
  7. Current guidelines for stroke management-Gujarat Medical Journal-Aug-99 Page 27-30
  8. Prolonged fasting-How is it possible-A Hypothesis-Gujarat Medical journal-march-2001 page 31-35
  9. Current concepts in the management of Ischemic stroke- Gujarat Medical Journal, March2001,Vol.58,Page 43-45.
  10. An approach to a patient of Dementia-Gujarat Medical journal- December-2001, vol.58, No 3, Page no. 33-35.
  11. Comprehensive medical approach to a case of refractory Epilepsy, Aspects of Epilepsy- Issue No-12, March 2002, Page 3-9.
  12. Sleep, its disorders and their treatment-Gujarat Medical Journal-Aug-2003, vol. 60, No. 2, Page No 17-21.
  13. Case report- Autoimmune Myasthenia Gravis in two brothers, JAPI, Vol.52, March 2002,Page 253-254.
  14. Dopaminergic Therapy for parkinsonís disease,current status : Parkinsonís disease and Movement Disorder, Page 217-227, Text chapter.
  15. Treatment for parkinsonís disease, current status, The journal of Association of Physicians of Gujarat,2004,Issue No.2,Page 40-57.
  16. Co-author for POSTENCEPHALITIC BILATERAL NIGRAL NECROSIS WITH MOTOR COMPLICATIONS Ėa poster presentation at conference for movement disorder at TOKYO, JAPAN-2006.
  17. Paper presented on Neurological Complication of Chiken Gunya at XVth Annual conference of IAPSM Ė GC on 18.1.2008.
  18. Co-author in Catheterization and Cardiovascular Interventions journal for Transradial approach for stenting of vertebrobasilar stenosis : A feasibility Study Published Online : 8th May 2009. Tejas Patel, MD, FACC, FSCAI 1*, Sanjay Shah, MD 1, Hemant Malhotra, MD 1 , Leena Shah, MD 1 , Sudhir Shah MD 2
  19. Co-author in journal of Clinical Virology for Systemic involvements and fatalities during Chikungunya epidemic in India, 2006. Babasaheb V. Tandalea, Padmakar S. Sathea, Vidya A. Arankallea, R.S.Wadiab, Rahul Kulkarnib, Sudhir V. Shah, et al

(B) I have done pioneering work on setting stroke protocols in Gujarat. Also has experience of doing successful intra arterial thrombolysis in acute ischemic stroke for more than dozen cases and have established standards of acute stroke unit as well as acute neurological intensive care and as director of neurosciences, I have developed model NICU at sterling hospital.

(C) I have given several lectures at state, national and international conferences on Neurology subjects.

(D) I have led the delegation for Indo-Japanese meet at Tokyo, Japan in May 2004, as principal speaker on - Peripheral Neuropathy an Indian perspective.

(E) I have given talks on Neurotheology-Neurological (scientific) basis for spiritual practices(e.g. meditation, religion etc.)at USA,UK, JAPAN Kenya etc.


  1. Open lable multicentric clinic trial to evalute the efficacy and safety of Entacapone as an add on therapy in the treatment of Parkinson’s disease.
  2. Evolution of Zonisamide as an adjunctive therapy in patient with refractory partial epilepsy – an open lable multicentric trial.
  3. A phase I / II multicentre, prospective, randomized parallel designs, placebo controlled,double blind study to evaluate the safety and efficacy of two different dosage requirement of a herbal preparation LLL – 2011 and placebo as a preventive treatment in patient with common migraine.
  4. A 24 week multicentre randomized, double blind, placebo controlled evolution of the efficacy,safety and tolerability of Donepezil Hydrocloride [ E2020-A001-319] in patient with Dementia associated with carebrovascular disease.
  5. A open – lable, multicentric, one year examination of the safety of Donepezil Hydrochloride [ E- 2020-A001-320] in patient with dementia associated with cerebrovascular disease.
  6. A phase III, multi-center, placebo-controlled, double blind, randomized, parallel group study to establish the efficacy of LLL-2011 administered as a 1% nasal spray in the preventive treatment of common migraine.
  7. Neuropathic pain: Efficacy of Pregabalin

(G) RESEARCH – TRIALS (Ongoing Trials)

  1. Study OV-1012: Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Clobazam (0.25, 0.5 and 1.0 mg/kg/day) in Patients with Lennox-Gastaut Syndrome Study OV-1004: Safety and Effectiveness of Open –Label Clobazam in Subjects with Lennox- Gastaut Syndrome
  2. A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial, with Placebo Run-In, and an Open-LabelTreatment Period, to Evaluate the Performance of the Cogstate Computerized Neuropsychological Battery and the ADAS-Cog in Generally Cholinesterase- naive AD Patients Randomized to Either Donepezil or Placebo
  3. A Randomized, Multicenter, Placebo-Controlled and Active Reference (Glatiramer Acetate) Comparison Study to Evaluate the Efficacy and Safety of BG00012 in Subjects With Relapsing-Remitting Multiple Sclerosis

(H) Extra Ordinary Case Study

  • Over whelming success in research activity “ Prahlad K. Jani ”. We have monitored him 24 hours for 10 days for validation of his claim for not eating, drinking, not passing stool and urine.
  • This project was widely telecasted all over the world including Discovery, BBC and in other electronic media.